UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 649

Sortiert nach

Reply to Johnson

The Journal of infectious diseases, 2021-08, Vol.224 (3), p.554-555

2021

Volltextzugriff (PDF)

Cost of Hospitalization Associated With Respiratory Syncytial Virus Infection Versus Influenza Infection in Hospitalized Older Adults

The Journal of infectious diseases, 2020-08, Vol.222 (6), p.962-966

2020

Volltextzugriff (PDF)

A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination

Vaccine, 2023-01, Vol.41 (3), p.844-854

2023

Volltextzugriff (PDF)

Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study

Vaccine, 2023-06, Vol.41 (24), p.3636-3646

2023

Volltextzugriff (PDF)

Incidence and clinical outcomes of pneumonia in persons with down syndrome in the United States

Vaccine, 2023-07, Vol.41 (31), p.4571-4578

2023

Volltextzugriff (PDF)

Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study

Vaccine, 2023-06, Vol.41 (29), p.4212-4219

2023

Volltextzugriff (PDF)

Tdap vaccination during pregnancy and risk of chorioamnionitis and related infant outcomes

Vaccine, 2023-05, Vol.41 (22), p.3429-3435

2023

Volltextzugriff (PDF)

Mortality risk after COVID-19 vaccination: A self-controlled case series study

Vaccine, 2024-03, Vol.42 (7), p.1731-1737

2024

Volltextzugriff (PDF)

Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data

American journal of epidemiology, 2023-02, Vol.192 (2), p.205-216

2023

Volltextzugriff (PDF)

Impact of the change of copay policy in Medicare Part D on zoster vaccine uptake among Medicare beneficiaries in a managed care organization

BMC health services research, 2017-07, Vol.17 (1), p.503-503, Article 503

2017

Volltextzugriff (PDF)

Risk of Herpes Zoster and Disseminated Varicella Zoster in Patients Taking Immunosuppressant Drugs at the Time of Zoster Vaccination

Mayo Clinic proceedings, 2015-07, Vol.90 (7), p.865-873

2015

Volltextzugriff (PDF)

COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021

MMWR. Morbidity and mortality weekly report, 2021-10, Vol.70 (43), p.1520-1524

2021

Volltextzugriff (PDF)

Receipt of Thyroid Hormone Deficiency Treatment and Risk of Herpes Zoster

International journal of infectious diseases, 2017-06, Vol.59 (C), p.90-95

2017

Volltextzugriff (PDF)

Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection

The Journal of infectious diseases, 2020-10, Vol.222 (8), p.1298-1310

2020

Volltextzugriff (PDF)

Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study

BMJ (Online), 2021-12, Vol.375, p.e068848

2021

Volltextzugriff (PDF)

The Epidemiology of Herpes Zoster in Immunocompetent, Unvaccinated Adults ≥50 Years Old: Incidence, Complications, Hospitalization, Mortality, and Recurrence

The Journal of infectious diseases, 2020-08, Vol.222 (5), p.798-806

2020

Volltextzugriff (PDF)

Population-Based Epidemiological Study of Neurological Diseases in Taiwan: I. Creutzfeldt-Jakob Disease and Multiple Sclerosis

Neuroepidemiology, 2009-01, Vol.33 (3), p.247-253

2009

Volltextzugriff (PDF)

Reply to Chu et al

The Journal of infectious diseases, 2023-02, Vol.227 (3), p.466-467

2023

Volltextzugriff (PDF)

Investigating Tetanus, Diphtheria, Acellular Pertussis Vaccination During Pregnancy and Risk of Congenital Anomalies

Infectious diseases and therapy, 2023-02, Vol.12 (2), p.411-423

2023

Volltextzugriff (PDF)

Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan

Journal of oral pathology & medicine, 2008-05, Vol.37 (5), p.271-277

2008

Volltextzugriff (PDF)

End-stage renal disease in Taiwan: a case-control study

Journal of epidemiology, 2009, Vol.19 (4), p.169-176

2009

Volltextzugriff (PDF)

Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged ≥60 Years

The Journal of infectious diseases, 2016-06, Vol.213 (12), p.1872-1875

2016

Volltextzugriff (PDF)

Real-World Evidence for Regulatory Decisions: Concomitant Administration of Zoster Vaccine Live and Pneumococcal Polysaccharide Vaccine

American journal of epidemiology, 2018-09, Vol.187 (9), p.1856-1862

2018

Volltextzugriff (PDF)

Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older

Vaccine, 2021-02, Vol.39 (6), p.926-932

2021

Volltextzugriff (PDF)

Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5

Nature communications, 2023-01, Vol.14 (1), p.189-189, Article 189

2023

Volltextzugriff (PDF)

1 – 25 von 649

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(561)
Mit Volltextzugriff
(608)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Reply to Johnson

Cost of Hospitalization Associated With Respiratory Syncytial Virus Infection Versus Influenza Infection in Hospitalized Older Adults

A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination

Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study

Incidence and clinical outcomes of pneumonia in persons with down syndrome in the United States

Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study

Tdap vaccination during pregnancy and risk of chorioamnionitis and related infant outcomes

Mortality risk after COVID-19 vaccination: A self-controlled case series study

Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data

Impact of the change of copay policy in Medicare Part D on zoster vaccine uptake among Medicare beneficiaries in a managed care organization

Risk of Herpes Zoster and Disseminated Varicella Zoster in Patients Taking Immunosuppressant Drugs at the Time of Zoster Vaccination

COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021

Receipt of Thyroid Hormone Deficiency Treatment and Risk of Herpes Zoster

Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection

Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study

The Epidemiology of Herpes Zoster in Immunocompetent, Unvaccinated Adults ≥50 Years Old: Incidence, Complications, Hospitalization, Mortality, and Recurrence

Population-Based Epidemiological Study of Neurological Diseases in Taiwan: I. Creutzfeldt-Jakob Disease and Multiple Sclerosis

Reply to Chu et al

Investigating Tetanus, Diphtheria, Acellular Pertussis Vaccination During Pregnancy and Risk of Congenital Anomalies

Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan

End-stage renal disease in Taiwan: a case-control study

Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged ≥60 Years

Real-World Evidence for Regulatory Decisions: Concomitant Administration of Zoster Vaccine Live and Pneumococcal Polysaccharide Vaccine

Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older

Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5

Suchergebnisse filtern